Please wait a minute...
Reviews in Cardiovascular Medicine  2011, Vol. 12 Issue (4): 186-199     DOI: 10.3909/ricm0581
Review Previous articles | Next articles
Clinical Impact of Renal Dysfunction in Heart Failure
Alberto Palazzuoli1, Matteo Beltrami1, Savina Nodari2, Peter A. McCullough3, Claudio Ronco4
1 Department of Internal Medicine, Cardiology Section, Santa Maria alle Scotte Hospital, Siena, Italy
2 Department of Cardiology, University of Brescia, Italy
3 St. John Providence Health System, Providence Park Heart Institute, Novi, MI
4 Department of Nephrology, San Bortolo Hospital, Vicenza, Italy
Download:  PDF(338KB)  ( 173 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Renal impairment in heart failure (HF) patients has been increasingly recognized as an independent risk factor for morbidity and mortality. In the most recent European and American guidelines for HF management, renal dysfunction was considered an index of poor prognosis independent of the presence of other traditionally investigated risk factors. Different mechanisms appear to be implicated in worsening renal function in patients with acute decompensated HF (ADHF) in contrast to chronic HF. In patients with acute ADHF, renal impairment has been attributed to renal hypoperfusion due to reduced cardiac output and decreased systemic blood pressure. In these patients, neurohormonal activation of the renin-angiotensin and sympathetic nervous systems plays a key role. In chronic and clinically stable HF, other mechanisms, including microvascular damage, oxidative stress, inflammation, and fibrosis, lead to a reduced number of functioning nephrons. Differentiating transient functional changes in renal filtration and acute renal tubular injury with loss of functioning nephrons is a critical step in understanding cardiorenal syndromes and selection of patients for novel therapeutic approaches.
Key words:  Chronic kidney disease      Heart failure      Cardiorenal syndrome      Mortality     
Published:  30 December 2011     

Cite this article: 

Alberto Palazzuoli, Matteo Beltrami, Savina Nodari, Peter A. McCullough, Claudio Ronco. Clinical Impact of Renal Dysfunction in Heart Failure. Reviews in Cardiovascular Medicine, 2011, 12(4): 186-199.

URL: 

https://rcm.imrpress.com/EN/10.3909/ricm0581     OR     https://rcm.imrpress.com/EN/Y2011/V12/I4/186

[1] Meer Fakhry, Mandeep S. Sidhu, Sripal Bangalore, Roy O. Mathew. Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney disease[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 157-162.
[2] Anthony (Ming-yu) Chuang, Mau T Nguyen, Woon-Man Kung, Sam Lehman, Derek P Chew. High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 191-203.
[3] Chiara Minà, Laura Ajello, Gabriele Di Gesaro, Calogero Falletta, Francesco Clemenza. Hyperkalemia in heart failure: current treatment and new therapeutic perspectives[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 241-252.
[4] Peter A. McCullough, John Eidt, Janani Rangaswami, Edgar Lerma, James Tumlin, Kevin Wheelan, Nevin Katz, Norman E. Lepor, Kris Vijay, Sandeep Soman, Bhupinder Singh, Sean P. McCullough, Haley B. McCullough, Alberto Palazzuoli, Gaetano M. Ruocco, Claudio Ronco. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 1-7.
[5] Amir Kazory, Maria Rosa Costanzo. The dynamic relationship between serum chloride and cardiorenal syndrome[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 25-29.
[6] Megan S. Joseph, Maryse Palardy, Nicole M. Bhave. Management of heart failure in patients with end-stage kidney disease on maintenance dialysis: a practical guide[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 31-39.
[7] Xiaogen Chen, Chunna Jin, Lan Xie, Meixiang Xiang. LCZ696 and preservation of renal function in heart failure: A meta-analysis of 6 randomized trials[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 113-118.
[8] Akanksha Agrawal, Hafeez Ul Hassan Virk, Iqra Riaz, Deepanshu Jain, Byomesh Tripathi, Chayakrit Krittanawong, Benham Bozorgnia, Vincent Figueredo, Peter A. McCullough, Janani Rangaswami. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 123-127.
[9] Michele Provenzano, Giuseppe Coppolino, Teresa Faga, Carlo Garofalo, Raffaele Serra, Michele Andreucci. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 209-220.
[10] Faeq Husain-Syed, Horst-Walter Birk, Khodr Tello, Manuel J. Richter, Claudio Ronco, Peter A. McCullough, Tanja Schörmann, Fiorenza Ferrari, Gökhan Yücel, Babak Yazdani, Hans-Dieter Walmrath, Werner Seeger, Henning Gall, H. Ardeschir Ghofrani. Alterations in Doppler-derived renal venous stasis index during decompensation of right heart failure and fluid overload in a patient with pulmonary hypertension[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 263-266.
[11] Hesam Mostafavi Toroghi, Kevin Bryan Lo, Mary Rodriguez Ziccardi, Benjamin Horn, Napatt Kanjanahattakij, Erum Malik, Jorge Penalver, Janani Rangaswami, Shuchita Gupta, Aman Amanullah. Renal implications of pulmonary arterial capacitance in acute heart failure with preserved ejection fraction[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 267-272.
[12] Girish Singhania, Abutaleb A. Ejaz, Peter A. McCullough, Aaron Y. Kluger, Saravanan Balamuthusamy, Bhagwan Dass, Namrata Singhania, Adhish Agarwal. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 111-120.
[13] Wan Chin Hsieh, Anas Aboud, Brandon M. chael Henry, Mohamed Omara, Jaroslav Lindner, Jan Pirk. Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 161-169.
[14] Victoria E. Tril, Alla V. Burlutskaya, Lily V. Polischuk. Metabolic cardiomyopathy in pediatrics[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 73-80.
[15] Janani Rangaswami, Sandeep Soman, Peter A. McCullough. Key updates in Cardio-Nephrology from 2018: springboard to a bright Future[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 113-116.
No Suggested Reading articles found!